More emphasis should be put on the advantages of providing HCV care for people who inject drugs in centralised rather than decentralised settings, possibly by expanding harm reduction programmes and integrating HCV services.
How to manage immunosuppressive agents in patients with rheumatoid arthritis who will require surgery, in order to avoid complications after surgery while limiting perioperative disease flares, is a critical question.
Poor cerebral collateral flow is associated with poor outcome after ischaemic stroke, and larger and faster infarct growth. Thus, therapeutic promotion of collateral flow may offer the chance to improve outcome.
Integrated care programmes can improve health-related quality of life, exercise capacity and hospital admissions in COPD patients.
An international peer-reviewed medical journal, established in 1871 as “Correspondenz-Blatt für Schweizer Aerzte”.
Newsletter for advertisers
Swiss Medical WeeklyEMH Swiss Medical Publishers Ltd.Farnsburgerstrasse 8CH-4132 MuttenzTel. +41 (0)61 467 85 55Fax +41 (0)61 467 85 56e-mail: Editorial office
EMH MediaSchweizerische ÄrztezeitungSwiss Medical ForumPrimary and Hospital CareCardiovascular MedicineSwiss Archives of Neurology, Psychiatry and PsychotherapySynapseSwiss Medical Informatics